Biotech Investment Analyst — Drug Asset & Company Assessment

Posted 5 Aug 2026

$120–200/hr

Apply

Platform

Mercor

Work

Remote · Part time · 15 hrs/wk · Remote — US-based or deep US-market experience

Experience

5+ years

Eligibility

Open to United States, Canada, United Kingdom, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden

Field

Finance & accounting

Skills

Biotech Investment AnalysisPharmaceuticalsDrug Development ProgramsClinical Data AnalysisMechanism of ActionCompetitive AnalysisDrug Asset AssessmentCompany AssessmentInvestment Thesis EvaluationRubric Design and Critique

About this role

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot,…

Read the full description on Mercor

Disclosure: Skillora is independent of Mercor. The apply button carries our referral code, and if you are placed, Mercor pays Skillora a fee. It does not change what you are paid. If Mercor asks you to confirm a referrer, it is Skillora’s founder.

All AI training jobs